drugset / Trial / NCT01211028
Adipose CELL Derived Regenerative Endothelial Angiogenic Medicine
Phase 1/2
Completed
13 enrolled
University Hospital, Toulouse
Centre National de la Recherche Scientifique, France · collabClinical Research Center, Toulouse · collabFrench Blood Establishment · collab
NaSingle-groupOpen-labelTreatment
Summary
The main purpose of this study is to evaluate the safety and feasibility of regenerative therapy with expanded adipose derived stroma/stem cells sue, administered intramuscularly in patients with critical leg ischemia.
Timeline
- Start
- 2009-01
- Primary completion
- 2012-07
- Completion
- 2012-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Expanded autologous ASCs | Cell therapy | 100 cells | Intramuscular |